4rlk
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4rlk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4rlk OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4rlk RCSB], [http://www.ebi.ac.uk/pdbsum/4rlk PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4rlk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4rlk OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4rlk RCSB], [http://www.ebi.ac.uk/pdbsum/4rlk PDBsum]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/CSK2A_MAIZE CSK2A_MAIZE]] Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Revision as of 19:03, 24 December 2014
Crystal structure of Z. mays CK2alpha in complex with the ATP-competitive inhibitor 4-[(E)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate
| |||||||||||
